Preliminary observations on the effects of meloxicam in a new model for acute intra-articular inflammation in dogs
- PMID: 7985384
- DOI: 10.1007/BF01839271
Preliminary observations on the effects of meloxicam in a new model for acute intra-articular inflammation in dogs
Abstract
The effects of intra-articular injection, on two occasions, 3 weeks apart, of the contrast agent Urografin on the cytological and biochemical characteristics of synovial fluid (SF) were examined in two studies in dogs. The first study provided baseline data in two non-medicated dogs. The second study used a cross-over design whereby 4 dogs received a 7-day oral treatment with either a placebo or meloxicam (0.2 mg/kg body weight daily) with a washout period of 3 weeks, in order to determine the effect of this new non-steroidal anti-inflammatory drug (NSAID) on the response to Urografin injection. SF samples were collected under general anaesthesia prior to and at 24 and 72 h after each Urografin injection. The volume, relative viscosity, white blood cell count and concentrations of protein, lactate dehydrogenase (LDH) and hyaluronic acid of these samples were determined. The results from both studies indicate that intra-articular injection of Urografin provoked a mild local transient inflammatory response, the most dramatic evidence of which was an increase in the white blood cell count in the SF after 24 h. In the second study, comparison of the synovial fluid measurements of the placebo-treated dogs at 24 h after Urografin injection with those prior to injection revealed significant increases in SF volume, white blood cell count, protein concentration and LDH activity and a significant reduction in relative viscosity. At 72 h after injection, only the white blood cell count and relative viscosity were significantly different from the pre-injection values.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.Vet Res Commun. 1999 Mar;23(2):101-13. doi: 10.1023/a:1006254402163. Vet Res Commun. 1999. PMID: 10359154
-
Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.Am J Vet Res. 2008 Sep;69(9):1203-9. doi: 10.2460/ajvr.69.9.1203. Am J Vet Res. 2008. PMID: 18764695 Clinical Trial.
-
Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs.Am J Vet Res. 1997 Jun;58(6):626-31. Am J Vet Res. 1997. PMID: 9185970 Clinical Trial.
-
Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.Br J Rheumatol. 1996 Apr;35 Suppl 1:4-12. doi: 10.1093/rheumatology/35.suppl_1.4. Br J Rheumatol. 1996. PMID: 8630636 Review.
-
[Meloxicam (Mobic): a review of its pharmacological and clinical profile].Nihon Yakurigaku Zasshi. 2002 Dec;120(6):391-7. doi: 10.1254/fpj.120.391. Nihon Yakurigaku Zasshi. 2002. PMID: 12528470 Review. Japanese.
Cited by
-
Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis.Can Vet J. 2000 Apr;41(4):296-300. Can Vet J. 2000. PMID: 10769766 Free PMC article. Clinical Trial.
-
Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.Vet Res Commun. 1999 Mar;23(2):101-13. doi: 10.1023/a:1006254402163. Vet Res Commun. 1999. PMID: 10359154
-
Distribution of lactate dehydrogenase in healthy and degenerative canine stifle joint cartilage.Histochem Cell Biol. 2007 Jul;128(1):7-18. doi: 10.1007/s00418-007-0287-5. Epub 2007 Jun 1. Histochem Cell Biol. 2007. PMID: 17541624
-
Dose-response relationship for the antipyretic effect of meloxicam in an endotoxin model in cats.Vet Res Commun. 1995;19(4):321-30. doi: 10.1007/BF01839314. Vet Res Commun. 1995. PMID: 8540243
References
MeSH terms
Substances
LinkOut - more resources
Medical